Prospectus Supplement Reveals $25M Equity Line and Nasdaq Delisting Notice
ONMD sits 19% above its 52-week low of $0.49 on light trading volume (0.4× avg).
Summary
A prospectus supplement for a $25 million equity line and a Nasdaq delisting notice underscore the company's precarious financial position.
Key Events · Financing and Capital Events · ONMD
-
New $25M Equity Line
On July 1, 2026, the company entered into a new Standby Equity Purchase Agreement with Yorkville, allowing it to sell up to $25 million of common stock at 97% of market price over 36 months.
-
Nasdaq Delisting Notice
A Nasdaq notice was received on April 14, 2026, for failing to maintain a $1.00 minimum bid price, with a compliance deadline of October 12, 2026.
-
Going Concern Warning
Cash of $0.4 million is insufficient to fund operations for 12 months, raising substantial doubt about the company's ability to continue as a going concern.
-
Related Party Subscription
In July 2026, the company issued 1,449,275 shares at $0.69 per share to a related party investor, generating $1.0 million in gross proceeds.
Analysis · ONMD · Industrial Applications And Services
The 424B3 prospectus supplement includes the Q2 2026 Form 10-Q, which discloses a new $25 million Standby Equity Purchase Agreement with Yorkville, a $1 million related party subscription, and a Nasdaq delisting notice. With only $0.4 million in cash, the company cannot fund operations for the next 12 months, raising substantial doubt about its ability to continue as a going concern. The new equity line offers critical capital but is highly dilutive, and the Nasdaq delisting notice adds urgency to the company's need to regain compliance.
At the time of this filing, ONMD was trading at $0.58 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $34.6M. The 52-week trading range was $0.49 to $4.22. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.